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AB S T R A CT  
In the world, there are many systems of traditional medicine. Cancer is the major public health burden 
both in developing and developed countries. Around 50% of existing medicines for cancer treatment 
have plants origin. Anticancer property of some plant extracts proven to be significantly effective in 
the treatment of cancer. Many herbs like sadabahar, turmeric, Kalonji, cannabis, garlic, flaxseed contain 
active components which may be effective in prevention and treatment of many cancers. The present 
review focuses on the evidence of health benefit of various herbs though recent human and animal 
studies.   
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1 Introduction 
Hippocrates was the father of western medicine. 
He used the term “cancer” for the first time. The 
Greek word is “carcinoma and Karakinos” used to 
express cancer [1].  Cancer is the leading cause of 
death in the age group 45-65yrs in the developed 
countries. Cancer is surpassing the other fatal 
diseases for morbidity due to change of lifestyle, 
food habits and non availability of curative 
treatment for many diseases [2]. World Health 
Organisation (WHO) predicts that around 15 
million new cases of cancer in 2020 [3]. Surgery, 
radiotherapy, and chemotherapy are the standard 
techniques of treatment of cancer. These 
standard techniques are costly, and having serious 
side effects affecting the quality of life like nausea, 
stomaties, diarrhea, and anemia 
thrombocytopenia of cancer patients [4]-[6]. 
Besides the severe side effects of chemotherapy 
and radiotherapy, these therapies also develop 
gradual resistance of cancer cells against the 
treatment [7].  
According to WHO report, more the 80% of 
population in the developing countries primarily 
employ traditional medicine for various diseases, 
Herbal medicine has been known for their 
efficacy, their affordability, availability and safety 
[8]. Many plants are loaded with chemo 
protective agents and play important role in 
controlling cancer symptoms and treatment. 
Herbal preparation plays a vital role in treatment 
and prevention of cancer.  Inhibition of mitosis 
is the basis of cancer therapy. Several studies 
indicate that medicinal plants have anti-cancer 
activity. Medicinal plants are cheaper, easily 
available and usually cause no toxicity as 
compared to the allopathic drugs [9]. From 1984 
to 1994, FDA confirmed that 60% of drugs were 
prepared from the natural sources specially from 
plant origin [10]. From 121 approved drugs for 
cancer treatment, 90 were derived from herbal 
medicine. From 1981 to 2002, 65 new drugs were 
registered for the treatment of cancer out of 
which 48 having natural products including: 
• Vinca alkaloids: Vincristine, Vinbalstin, 
Vindesine, Vinorelbine 
• Taxanes: Paclitaxel, docetaxel 
• Podphyllotoxin and its derivatives: 
Topothecon, irinothecan 
• Anthracyclines: Doxorubicin, Daunorubicin, 
epirubicin, idarubicin [7,11]. 
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Ayurveda tried many herbal and Rasayana 
remedies with varying success, but their main 
approach is preventive [12]. These anti-cancer 
herbs inhibiting cancer activating enzymes and 
stimulate the DNA repair mechanism and also 
promote the anti-oxidant action, Hence, 
enhancing the immune cells activity. Some herbs 
also reduce the side effects of chemotherapy and 
radiotherapy. Hence, herbal preparation can be 
propose to kill cancer cells devoid any harm to 
normal cells and side effects of traditional anti-
cancer therapies   
2 Herbal Drugs 
Herbal drugs include Plants, combination of 
plants, herbal complexes. Herbal plants were 
used all over the world in different form both in 
allopathic and traditional medicine [13].  
2.1 Kinds of Herbal Medicines 
Herbal medicines are divided in to two categories:  
A. Immuno-modulating Herbs 
B. Chemoprotective or Adapto genic herbs. 
2.1.1 Immuno-modulating Herbs  
play key important role in the treatment of cancer 
patients by enhancing their immunity. Since, 
cancer cells decrease the surveillance of immune 
system due to low immunogenicity in the cancer 
patients. Majority of herbal medicine stimulate 
the immunity. In addition, these medicines 
protect the bone marrow against myelo-
suppressive effects of chemotherapy [1].  
2.1.2 Chemoprotective or Adaptogenic Herbs 
Chemopreventing Herbal medicines inhibit the 
development of carcinogenic by inducing 
apoptosis [14, 15]. Curcumin induce the 
apoptosis in cancer cells by blocking NF-KB 
signalling pathway through controlling IKB 
enzyme phosphorylation [16,17].   The main aim 
of herbal medicines in cancer treatment is the 
prevention of cancer by generating unfavourable 
environment for the cancer cells. In addition, 
prevention of recurrence by enhancing the 
immunity of the patient body and also reducing 
the side effects of chemotherapy and 
radiotherapy [1,3].   
2.2 Why People use Herbal Medicine 
Around 75-80% population in the developing 
countries use herbal medicine for the treatment 
of cancer [18]. Patients suffering from cancer are 
inclined to use herbal medicine due to hope to 
cure cancer, to prevent metastasis, enhance 
immunity, reduce stress, and feel relaxed [19].   
We reviewed some well-known and easily 
available herbs which can be used prevention 
therapy of cancer as an adjuvant therapy.  
3 Health Benefits of Different Herbs 
3.1 Catharanthus Roseus or Vinca Rosea 
(Periwinkle) 
Vinca resea (Periwinkle) was the first anti cancer 
herb. Periwinkle contains vinca alkaloids which 
contains vincristine (leurocrystine) , vinblastin, 
alstonine, ajmalicine and reserpine [20,21]. In 
1960 the alkaloids of vincristin (VCR) and 
vinblastin (VBT) are the first having anti cancer 
property [14].  These alkaloids show anticancer 
property by binding with tubulin (microtubule 
protein). Therefore, microtubules breakdowns 
and inhibits the formation of spindes in the 
metaphase hence, stop the division of cancerous 
cells [22, 23]. Vincristine and vinblastin both are 
significantly different in their structure and utility 
(Figure 1). 
 
Figure 1: Molecular structure of  (a) vinblastine (b) Vincristine [24] 
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Figure 2: Molecular structure of curcumin [28] 
 
 
Figure 3: Action of curcumin [29] 
Vinblastine used in the treatment of Hodgkin’s 
disease, non Hodgkin’s lymphoma and cancer of 
kidney. While, vincristine used with combination 
of other anticancer agents for treatment of 
lymphocytic leukaemia and cancer of breast, lung, 
liver, cervix [13]. Currently, herbal compounds of 
periwinkle have been approved by FDA to treat 
the neoplasm and vincristine is the commonly 
used drug for the treatment of breast cancer. 
3.1.1 Side Effects of Periwinkle 
Vinblastine has some side effects like bone pain, 
loss of appetite, misery, dizziness, constipation, 
hair loss and stomach pain.  
3.2 Curcuma Longa (Turmeric): 
In Indian food turmeric use as a spice to add 
color and flavour. Curcuma Longa (CL) shows 
wide spectrum of therapeutic effects. It contains 
curcumin, which is the highly pleiotropic molecule 
(Figure 2). CL is anti-oxidant, anti-inflammatory, 
anti-mutagenic, anti-tumour, anti-fungal, anti-
viral, anti-bacterial and hepatoprotective [25]. 
Curcumin prevents the production of harmful 
eicosanoid such as PGE-2 hence, inhibits the 
growth of cancer cells [13]. Administration of 
1g/day of turmeric up to 9 months exerted 
significant effects on the regression of 
precancerous lesion of palatal cancers [26]. No 
acute toxicity effect was observed in the 
administration of turmeric powder with a dose up 
to 10 g/kg [27]. Curcuminoids extracted from 
Curcuma longa (Turmeric) such as curcumin (Di-
feruloyl-methane) suppress cancer cells at every 
step, i.e. initiation, growth and metastasis. 
Curcumin arrests the cancer cell proliferation in 
G2/S phase and induces programmed cell death 
(apoptosis). It inhibits angiogenesis which is a 
critical step in the growth and metastasis of 
cancer. Figure 3 shows the action mechanism of 
curcumin for brain tumour. 
4 
 
ISSN: 2456-7132 
Available online at Journals.aijr.in 
Anticancer Herbs for Improving the Quality of Life 
Curcumin used to care for squamaous cell 
carcinoma of skin and ulcerated oral cancer. It 
also prevents malignant transformation of 
leukoplakia [14]. Curcumin   and  Genistein  
(isolated  from Glycine  max)  act  synergistically  
to  inhibit growth  &  spread  of  oestrogen-
positive breast cancer cells. 
 
Table 1: Active components of Nigella Sativa 
Group Sub Group Active Components 
Alkaloida - Nigrllicine, 
Nigellidine, 
Nigellimine – N- 
Oxide 
Coumarins - 6-methoxy-
coumarin, 7 hydroxy 
coumarin, 7 oxy 
coumarin. [33]-[35] 
Saponins Triterpenes Alpha Hedrin 
Steroidal Steryl gluosides, 
Ncetyl steryl 
Gluocoside [36] 
Carbohydrates 
(33.9%) 
- - 
Fixed Oil (32-
40%) 
Saturated 
fatty acid 
Palmitic, Stearic, 
and myristic acid, 
Beta-sitosterol, 
Cycloeucalenol, 
Cycloartenol, Sterol 
ester, and Sterol 
glucosides [37] 
Unsaturated 
Fatty Acid 
Arachdonic, 
eicosadienoic, 
linoleic, linolenic 
oleic and almitoleic 
acid [37] 
Protein (16-
19.9%) 
Amino acid Arginine, glutamic 
acid, leucin, lysine, 
proline [38] 
Fiber (5.5%) - - 
Minerals 
(1.79-3.74%) 
- - 
Water (6%) - - 
Volatile Oil 
(0.4-0.45%) 
- Nigellone, 
thymoquinone, 
thymohydroquinone, 
dithymoquinone, 
thymol, carvacrol 
[38,39] 
 
3.3 Nigella Sativa (Kalonji) 
Nigella Sativa uses to promote health and fight 
disease especially in Middle East, Southeast Asia.  
Nigella sativa has been used for the treatment of 
various diseases. In south Asia it is known as 
kalonji. The Arabic name of Nigella Sativa is 
Habat-ul-Sauda and in English it is called black 
cumin [30]. It is an annual herb and used as 
natural medicine and cultivated in different parts 
of India and Pakistan. Traditionally, it is used to 
promote general health conditions and in the 
cold, headache, microbial infections. It is also use 
as a diuretic diaphoretic, stomachic, liver tonic, 
and digestive. Nigella Sativa improves the 
immune system when administered 1gm twice a 
day reported by researcher [31] Kalonji also 
enhances the immune system by improving 
helper T Cells (T4) to suppressor T cells (T8) 
ratio and improving the natural killer cell activity 
with decrease in the immune globulin (IgA, IgG, 
and IgM) level [32]. Thymoquinone is the active 
component of Nigella Sativa shown in the figure 
4. The chemical composition and active principle 
components of Nigella Sativa is indicated in 
Table 1 [25].  
 
Figure 4: Structure of thymoquinone [28] 
 
3.4 Anti-cancer Activity of Nigella Sativa 
Nigela Sativa, has been used as a tonic to promote 
heath and treatment of various diseases [40]. It is 
immune-potentiating [39], immune-modulating, 
and has interferon like actions. Hailat et al; 
observed that the natural killer cell activity 
enhanced by 200-300% for advanced cancer 
patients receiving multimodality immune therapy 
in which kalonji was one of the components. 
They also investigated the anti-cancer activity of 
Nigella Sativa on cancer cell lines and in animal 
model. Ethanolic extract of NIgella Sativa inhibits 
cancer cells and progression of endothelial cells 
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in-vitro [41,42]. Alcoholic extract also used to 
cure oral cancer [43]. Alcoholic extract either 
alone or in combination with H2O2was found to 
be effective in inactivating MCF-7 breast cancer 
cells in vitro [44].  
Active components of Nigella Sativa, 
Thymoquinone and dithymoquinone have strong 
anticancer activity against various cancers [44], 
including prostate, pancreas, uterus, cancers of 
the colon, malignant lymphoma, malignant 
ascites, malignant melanoma, leukaemia and 
sarcomas. Thymoquinone is effective in both 
hormone-refractory and hormone-sensitive 
prostate cancer. Nigella sativa kills cancer cells by 
binding to the asialofeutin (lectin) on the surface 
of cancerous cells, causing their aggregation and 
clumping. Nigella sativa also possesses immune-
enhancing and anti-inflammatory properties.  It 
protects against liver cancer. Thymoquinone and 
dithymoquinone show cytotoxic effect on the 
multi drug resistant human tumour which was 10-
fold more resistant to doxorubicin and etoposide 
[45].  
3.4.1 Anti-Oxidant Property of Nigella Sativa 
Nigella Sativa also shows anti-oxidant property. 
Thymoquinone shows protective effects on 
haematological, hepatic conditions induced by 
anti-cancer drugs. Thymoquinone and fixed oil of 
Nigella Sativa also inhibit non-enzymetic 
peroxidation in oxbrain phospholipid liposomes. 
Hepatoprotective effect of Nigella Oil and 
thymoquinone is found to be due to anti-oxidant 
property [46,47]. Nigella Sativa with crystein, 
vitamin E and crocus sativa protect cisplatin 
induced haematological hepatic and renal 
toxicities [48]. Butits et al reported that the 
Essential oil of Nigella Sativa and its four 
constituents (thymoquinone, Carvacrol, t-anethol 
and 4-terpineol) exhibit anti-oxidant effect on 
various chemical assays like 
diphenylpicrylhydracryl assay, and assay for non-
enzymetics lipid peroxidation in liposomes and 
deoxyribose degradation assay [30,40].   
3.4.2 Toxicity Effect of Nigella Sativa 
There is acute toxic effect of Nigella Sativa when 
administered orally 25g/Kg. However, toxic 
symptom appears when 25g/kg is administered 
intravenously [22]. Nigella Sativa has significant 
effects on biological systems. It’s Ethanolic and 
aqueous extract as well as its volatile oil possess 
beneficial effects.   
3.5 Cannabis Sativa (Cannabis): 
Cannabis is the versatile material used to relief 
from pain, depression, nausea caused by 
chemotherapy in the treatment of cancer. It also 
works as the appetite suppressant. Δ9- 
tetrahydrocannabinol (THC) is the main 
constituent found in the cannabis (molecular 
structure is shown in figure 5) which is 
responsible for the pharmacological activity of 
cannabis in the medical field [49].  
 
Figure 5: Molecular structure of 
Tetrahydrocannabinol (THC) [28] 
THC produced unique psychosomatic effects in 
human, including sedation, euphoria, altered 
sensory input and impaired cognitive functions. 
It also effects on the vital organs like heart 
(tachycardia), lungs (alveolar dilation) [50]. THC 
has an anti-emetic effect on animal [51] and in 
human [52, 53]. In 1990, Plasse et. al; [54] 
demonstrate the positive effects of THC in 
appetite increase in HIV positive and cancer 
patients. Cannabinoids have two receptors CB1, 
andCB2 [55]. CB1 receptor found in brain, 
periphery tissue, sensory nerve fiber, testis and 
immune system [56]. The highest level of CB1 
receptor found in brain which is responsible for 
the neuropsychological functions altered by the 
cannabinoids [57].  CB2 receptor is mainly 
present in the immune tissue i.e; spleen, mast 
cells, peripherial blood leukocytes, thymus, 
pancreas, bone marrow, macrophages/ 
monocytes tonsils [56]. CB1and CB2 receptors 
are activated by THC [58]. Cachexia is the most 
common complication in the cancer patients 
which arises due to the metabolic changes created 
by tumours and cytoknines and other 
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endogenous substances [58]. Studies indicate that 
increase of appetite and weight gain with the 
intake of marijuana (cannabis) for cancer patients 
and AIDS related anorexia [59,60].  
Nausea and vomiting are associated with the 
cytotoxic drug effects (during chemotherapy) and 
radiation. The nausea and vomiting also suppress 
the appetite.  Nabilone (Cesamet) a synthetic 
derivative of THC is found to be effective in 
controlling chemotherapy induced nausea and 
vomiting [61]. Cannabinoids is also effective in 
treating nausea and vomiting for the children 
undergoing chemotherapy [62, 63].  
3.5.1 Toxicity Effect of Cannabis 
Side effects of cannabis are not often seen in the 
physical aspects, rather in mental or cognitive 
domain such as inability to recognised distant 
objects and time interval and memory processes.   
3.6 Allium Sativum (Garlic) 
 Initially Allium Sativam used in Egypt, Greece, 
Europe, India, China, Rome and Russia. Garlic 
has preventive potentials and has enhancing 
effects on immune system [28]. Hippocrates was 
the first who recommend the use of Allium 
Sativum for the treatment of cancer. More than 
100 biological metabolites are available in Allium 
Sativum, which includes Alliin, Allinase, Allicin, S-
allylcrystine (SAC), di-allyl-di-sulphide (DADS), Di-
allyl-tri-sulphide cristine (DATS) and Methyl-allyl-tri-
sulphide (molecular structure is shown in figure 
6) [64]. In Allium Sativum bioflavonoids: quercetin 
and cyaniding are responsible for the anti-oxidant 
property. DADS, SAC and DATS cristine have 
anti-cancer property. Garlic shows significant 
role in the treatment of intestine cancer. The 
anticancer effects of garlic are due to its 
metabolic by products of organo-sulphur 
components [65, 66]. These by products are 
DADS, SAC and DATS cristine and allicin [51].  
When MCF-7 (ER+) and MDA-MB231 (ER-ve) 
treated with S-allyl mercaptocystein, cancer cell 
growth was inhibited via inducing cell cycle arrest 
in G0 /G1 phase [67].  Cell cycle redistribution is 
the important role in human gastic cancer cells 
when treated Diallyl disulfied modulate anti-
carcigogenic effect [68]. A study of epidermiology 
indicates that the garlic reduces the risk of gastric 
cancer [69, 70].  
 Aged garlic produces from the fresh garlic for 
more than 10 months. The extract of aged garlic 
decrease the aberrant crypt foci (ACF) in 
colorectal cancer [71]. Extract from the aged 
garlic shield the DNA from the damaging effect 
of carcinogen, enhance the activity of detoxyfing 
enzymes, and increase the immunity of the body. 
Study from Dene National Medical centre and 
Hospital from Japan reveals that the extract of 
aged garlic can reduce the side effects of 
radiotherapy and chemotherapy [24, 25].  The 
compound extracted from the garlic extract is 
also useful in the treatment of other cancers. A 
compound extracted from the garlic, Z-ajoene is 
useful in the treatment of gioblastoma [25, 72]. 
Another sulphur compound of garlic extract 
Thiacremonone, inhibits the lung cancer cell 
growth via inhibiting the Gpx activity of 
peroxiredoxin 6 through interaction [73].   
 
 
Figure 6: Molecular Structure of- 
 (a) diallyl sulphide, (b) diallyl disulfide, (c) diallyl trisulfide, (d) S-allyl mercaptocysteine, (e) allicin 
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The mechanism showing the antitumor activity, 
stimulating the lymphocytes and macrophages 
used to kill cancer cells and interfaces with 
tumour cells metabolism is shown in figure 7.   
 
 
Figure 7: Mechanism of garlic showing antitumor 
activity 
3.7 Zingiber Officinale (Ginger) 
 Studies suggest that the ginger and its bioactive 
constituents such as gingerol, paradols and 
shogals [74] and they are useful in cancer 
prevention and treatment [89].  Gingerols 
isolated from Zingiber officinale inhibits growth 
& spread of various cancers including that of the 
ovary, cervix, colon, rectum, liver,  urinary  
bladder,  oral cavity,  neuroblastoma  and  
leukaemia  by inducing  apoptosis [24].  Gingerols 
are the series of phenolic compounds which are 
different in length in their unbranched alkyl side 
chain reposted by [76]. Figure 8, depicts the 
chemical structure of active constituents of 
gingerols. The most active individual component,  
6-shogaol,  isolated from Zingiber  officinale,  
inhibits growth  & spread  of  many  cancers  
particularly  the ovarian  cancer  by  blocking  
formation  of new blood vessels and by inducing 
apoptosis &  autophagy. 6-gingerol also inhibits 
adhesion, invasion and mobility of MDA-MB-
231 breast cancer cells [28] and also suppresses 
the proliferation of breast cancer cells by 
inducing apoptosis.  It is also effective even in 
chemotherapy resistant ovarian cancer. Zingiber 
officinale also possesses antioxidant, anti-
mutagenic and anti-inflammatory properties and 
reduces side effects of chemotherapy & 
radiotherapy. 
3.8 Flaxseeds 
Flaxseeds are the small golden brown coated 
seeds. They are also known as linseed. Their latin 
name is Linum usitatissimum which means very 
useful. They have potential health benefits like 
reduction of cardiovascular disease, diabeties, 
cancer, arthritis, osteoporosis and neurological 
disorders [77]. Flaxseeds contains all active 
ingredients like dietary fiber, omega-3 fatty acid, 
α- linolenic acid (ALA), short chain of 
polyunsaturated fatty acids (PUFA), lignin 
proteins and array of antioxidant [78]-[80]. 
Flaxseeds have estrogenic activity due to 
metabolism of lignon to enterodiol, 
enterolactone. This metabolism occurs in the 
digestive tract. Flaxseeds have dominant 
anticancer activity [81, 82]. Observational data of 
Gallian et al [98] demonstrate that flaxseeds are 
protective against breast cancer with the intak of 
¼ cup (approximately 32 grams ground 
flaxseeds) [83].  It also inhibits the colon, skin, 
and lung cancer. Several studies demonstrate that 
flaxseeds and its active components shows anti-
angiogenic [84] and increase apoptosis [85] effect 
hence, reducing the tumour size [101,102]. 
Nutritional and chemical composition of 
flaxseeds is available in Table 2.  
 
Figure 8: (a) Structure of 6-gingerol, (b) 6- Shogaol, (c) Paradol
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Table 1: Nutritional and chemical composition of 
Flaxseeds [77] 
Nutrients Quantity/ 
100g of 
seed 
Nutrients Quanti
ty/ 
100g of 
seed 
Carbohydrates 29.0g Potassium 831 mg 
Total fats 41.0 g Phosphorous 622mg 
Protein  20.0g Calcium 236 mg 
Linolenic acid 23.0g Magnesium 431mg 
Lignans 10-
2,600mg 
  
Folic Acid 112mg   
 
4 Conclusion 
Cancer is the major public health burden. Many 
herbs and plant products have been 
demonstrated to have anti-tumour activity.  Large 
population-based studies are required to study 
the preventive role of these (Kalonji, turmeric, 
Garlic, Cannabis, Flaxseed) herbs. Several herbs 
have anticancer effects on skin, breast, lung, 
prostate cancer (Shows in table 3). Some of the 
herbs may also be useful in increasing the 
therapeutic effect of radiotherapy and 
chemotherapy.  
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Table 3: Herbs and their anti- cancer effects 
H
er
b
 
Active 
Constituents 
Site Anticancer effect 
P
er
iw
in
k
le
 
Vincristine, 
Vinblastine  
All 
cancer 
Kill cancer cells 
T
u
m
er
ic
 
Curcumin Breast 
 
Inhibiting MCF-7 Cancer cells, cell 
invasion, sensitizing cancer cells to 
retinoic acid 
cervix exterminate cancer cells without 
affecting the normal cells, inducing 
the apoptosis  
Lung Inducing apoptosis, inhibiting the 
growth of cancer cells 
Liver Inhibiting the hepatoma cells 
growth and hepato-carcinogenesis 
Stomach Promoting apoptosis, and 
suppression of lymphatic vessels 
density, restrain cell growth 
Colorect
um 
Inhibit cell growth, prevent aberrant 
crypt foci, and inducing apoptosis 
Prostate Target AR and histone 
modification, inhibit cell 
proliferation 
K
al
o
n
ji
 
Thymoquinone Breast Anti-proliferative and pro-apoptotic 
effect 
Thymoquinone, 
Methanolic 
extract 
cervix Induced apoptosis and inhibit 
proliferation  
Seed oil, 
Thymoquinone, 
lung Reduce the cancer cell viability, 
inhibit cell migration and invasion 
of lung cancer cells 
Thymoquinone, liver Inhibit cell proliferation  
 
Thymoquinone, Colorect
um 
Attenuate the tumour cell growth, 
induced apoptosis, and autophagic 
cell death 
C
an
n
ab
is
 
Tetrahydrocanna
binol 
Cancer  Appetite stimulant, relief from pain, 
nausea and vomiting caused by 
chemotheraypy 
G
ar
li
c 
Diallyl sulfide, 
Diallyl disulfide, 
diallyl trisulfied, 
S-allyl 
mercaptocysteine 
Breast Inhibit cell growth, proliferation and 
metastasis, induced apoptosis, 
immune-modulation and inhibit the 
estrogen receptor α-activity 
 Lung  
Se-Methyl-L-
Selenocysteine 
Colorect
um 
Increase apoptosis, and reduce cell 
proliferation 
Z
in
g
ib
er
 O
ff
ic
in
al
e 6-Shagoals Breast Decrease angiogenesis, metastasis 
6-Shagoals Lung Decrease angiogenesis, metastasis 
Root/leaves 
extract, 6-
gingerol, 
shogaols 
Colorect
um 
Induce apoptosis, reduce cell 
viability and proliferation  
Ginger extract, 6-
gingerol, 6 
paradol 
 
Prostate 
Inhibit the growth of prostate cancer 
cells and induced apoptosis 
F
la
x
se
ed
 
omega-3 fatty 
acid, α- linolenic 
acid (ALA), 
short chain of 
polyunsaturated 
fatty acids 
(PUFA), lignin 
proteins and 
array of 
antioxidant 
Breast, 
Skin, 
Colon, 
Lung 
Inhibit angiogenesis, increase 
apoptosis,  
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